Enough whining, carping, and bad karma! No economic depression is looming and the end of the world as we know it is not at hand. Valuations are being readjusted, late, to reflect a FED-induced slower economy and correct excessive optimism in certain dicey sectors. In the process, Wall Street, as usual, is overdoing it on the down side. Chips, telephony, fiber, and biotechs -- they're all like last night's one night stand -- embarrassing to think about what was done -- and so far no consensus has emerged about the sectors which will "lead" the market higher.
Amidst all the negativity of The Crowd, however, there are some biotech related stocks that have held up comparatively well over the last twelve weeks. Here is a random list. Each has done fairly well and stands tall(er) amidst the rubble around them -- some because they were whacked earlier, others for reasons of their own.
Do any of these stocks promise long term gains from these levels? I think maybe so. What does everyone else think?
AMGN ELN BPUR IMCL SCIO BCHE GENZ AXCA MSS
And my current favorites - not pure bio plays -- DOW and MOT. |
